Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination
HISTOBLOC
1 other identifier
interventional
42
1 country
1
Brief Summary
Study to evaluate the use of confocal microscopy for detecting resection margins in patients undergoing surgery for basal cell carcinoma of skin and squamous Cell Carcinoma of Head and Neck
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2023
CompletedFirst Posted
Study publicly available on registry
July 7, 2023
CompletedStudy Start
First participant enrolled
November 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedNovember 28, 2025
November 1, 2025
1.6 years
June 27, 2023
November 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity and Specificity of Confocal Microscopy Diagnosis Compared to Gold Standard
The concordance of intraoperative diagnosis between the two methods will be assessed by the condition of the margins of surgical specimens. Diagnostic accuracy will be measured by the sensitivity and specificity of confocal microscopy, using conventional histology reports from extemporaneous examination as the gold standard. * negative margins (absence of tumour cells) ; * positive margins (presence of tumour cells).
1 day
Study Arms (1)
Microscopy confocal
EXPERIMENTALInterventions
Surgical margins of tumor samples will be examined by conventional histopathology (H\&E) and confocal microscopy (Histolog® scanner, SamanTree Medical, Switzerland). Depending on the histopathological result obtained between the two methods, the patient may benefit directly from early surgery if the experimental result confirms the presence of positive margins (excluding the learning curve). A learning curve will be established over the first fifteen surgeries, enabling surgical teams to gain experience and systematize specimen flattening. This learning curve will also enable reference images to be produced. The procedure will be carried out by the surgeon and the pathologist in the operating room during this phase.
Eligibility Criteria
You may qualify if:
- Adult patient ≥18 years old
- Squamous cell or basal cell tumor (1 to 4 cm) of mucous or cutaneous origin.
- Patient whose surgical indication has been validated in a consultation meeting
- Patients with scheduled surgery
- WHO\< or =2
- ASA \< 3
- Patient affiliated to the social security system
- Patient has understood, signed and dated the consent form.
You may not qualify if:
- History of irradiation in the surgical area
- Women who are pregnant or who are breast-feeding.
- Persons deprived of their liberty or under guardianship (including curators)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, 54500, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
GILLES DOLIVET, MD
Institut de Cancérologie de Lorraine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 27, 2023
First Posted
July 7, 2023
Study Start
November 28, 2023
Primary Completion
June 21, 2025
Study Completion
March 1, 2026
Last Updated
November 28, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share